An important limitation of most current AS protocol for PCa is their reliance on a one-size-fits-all approach with repeated PSA measurements, MRI, and prostate biopsies at fixed and predetermined intervals, irrespective of the individual’s risk. This evidence concerns the gene KLK3 and posterior cortical atrophy.